Cargando…
Liver enzymes among COVID-19 patients in Al-Ahsa region of Saudi Arabia
BACKGROUND: Hepatic damage is one of the common forms of extra pulmonary organ destructions among patients with COVID-19 infections. AIM: To evaluate the prognosis of liver damage among COVID-19 patients based on their liver enzymes profile. METHODS: A retrospective study was done to evaluate the re...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10151239/ https://www.ncbi.nlm.nih.gov/pubmed/37185176 http://dx.doi.org/10.1136/bmjgast-2023-001121 |
_version_ | 1785035497766125568 |
---|---|
author | AlOmair, Omar |
author_facet | AlOmair, Omar |
author_sort | AlOmair, Omar |
collection | PubMed |
description | BACKGROUND: Hepatic damage is one of the common forms of extra pulmonary organ destructions among patients with COVID-19 infections. AIM: To evaluate the prognosis of liver damage among COVID-19 patients based on their liver enzymes profile. METHODS: A retrospective study was done to evaluate the records of the hospitably admitted patient due to COVID-19 infection. Retrieved data included clinical presentation and investigation either imaging or laboratory with special investing in liver function tests. RESULT: We reviewed 442 patients who were diagnosed with COVID-19 infection. They were 64.5% of female patients and 35.5% of male patients. Their mean age was 54.5%, most of them were Saudi (76.7%) and the overall mortality reached up to (20.4%). CONCLUSION: This large cohort of 442 patients has shown that liver damage may be an independent prognostic factor for morbidities and mortality among COVID-19 patients. It also showed the importance of liver function enzymes screening as a predictor for the outcome of those patients. |
format | Online Article Text |
id | pubmed-10151239 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-101512392023-05-02 Liver enzymes among COVID-19 patients in Al-Ahsa region of Saudi Arabia AlOmair, Omar BMJ Open Gastroenterol Hepatology BACKGROUND: Hepatic damage is one of the common forms of extra pulmonary organ destructions among patients with COVID-19 infections. AIM: To evaluate the prognosis of liver damage among COVID-19 patients based on their liver enzymes profile. METHODS: A retrospective study was done to evaluate the records of the hospitably admitted patient due to COVID-19 infection. Retrieved data included clinical presentation and investigation either imaging or laboratory with special investing in liver function tests. RESULT: We reviewed 442 patients who were diagnosed with COVID-19 infection. They were 64.5% of female patients and 35.5% of male patients. Their mean age was 54.5%, most of them were Saudi (76.7%) and the overall mortality reached up to (20.4%). CONCLUSION: This large cohort of 442 patients has shown that liver damage may be an independent prognostic factor for morbidities and mortality among COVID-19 patients. It also showed the importance of liver function enzymes screening as a predictor for the outcome of those patients. BMJ Publishing Group 2023-04-25 /pmc/articles/PMC10151239/ /pubmed/37185176 http://dx.doi.org/10.1136/bmjgast-2023-001121 Text en © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Hepatology AlOmair, Omar Liver enzymes among COVID-19 patients in Al-Ahsa region of Saudi Arabia |
title | Liver enzymes among COVID-19 patients in Al-Ahsa region of Saudi Arabia |
title_full | Liver enzymes among COVID-19 patients in Al-Ahsa region of Saudi Arabia |
title_fullStr | Liver enzymes among COVID-19 patients in Al-Ahsa region of Saudi Arabia |
title_full_unstemmed | Liver enzymes among COVID-19 patients in Al-Ahsa region of Saudi Arabia |
title_short | Liver enzymes among COVID-19 patients in Al-Ahsa region of Saudi Arabia |
title_sort | liver enzymes among covid-19 patients in al-ahsa region of saudi arabia |
topic | Hepatology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10151239/ https://www.ncbi.nlm.nih.gov/pubmed/37185176 http://dx.doi.org/10.1136/bmjgast-2023-001121 |
work_keys_str_mv | AT alomairomar liverenzymesamongcovid19patientsinalahsaregionofsaudiarabia |